Testing effectiveness (Phase 2)Study completedNCT06274489What this trial is testingEvaluate Setanaxib in Patients With Alport SyndromeWho this might be right forAlport Syndrome Calliditas Therapeutics AB 20
Not applicableLooking for participantsNCT05996731What this trial is testingDeveloping a Pipeline to Employ RNA-Seq as a Complementary Diagnostic Tool in Rare DiseasesWho this might be right forAtypical Hemolytic Uremic SyndromeMembranoproliferative GlomerulonephritisAutosomal Dominant Polycystic Kidney+1 more Mario Negri Institute for Pharmacological Research 105
Post-approval studies (Phase 4)UnknownNCT01184599What this trial is testingA Prospective Study of the Kidney Protective Effect of Aliskiren in Hypertensive Patients With IgA NephropathyWho this might be right forGlomerulonephritis, IGAHypertension Kagawa University 30
Not applicableActive Not RecruitingNCT02194582What this trial is testingGenetic Causes of FSGS, Nephrotic Syndrome, or Kidney FailureWho this might be right forFocal Segmental GlomerulosclerosisNephrotic SyndromeEnd Stage Renal Disease+2 more Beth Israel Deaconess Medical Center 2,050
Not applicableEnrolling By InvitationNCT04571658What this trial is testingNEPTUNE Match StudyWho this might be right forNephrotic Syndrome in ChildrenFocal Segmental GlomerulosclerosisMinimal Change Disease+6 more University of Michigan 375
Testing effectiveness (Phase 2)UnknownNCT05448755What this trial is testingELX-02 in Patients With Alport SyndromeWho this might be right forAlport Syndrome Eloxx Pharmaceuticals, Inc. 8
Not applicableStudy completedNCT02136862What this trial is testingATHENA: Natural History of Disease Study in Alport Syndrome PatientsWho this might be right forAlport Syndrome Patients With eGFR Between 45-90 ml/Min/1.73 m2 Genzyme, a Sanofi Company 165
Large-scale testing (Phase 3)Not Yet RecruitingNCT06731192What this trial is testingHuman Umbilical Cord Mesenchymal Stem Cells for Alport SyndromeWho this might be right forAlport Syndrome Guangzhou Women and Children's Medical Center 40
Not applicableStudy completedNCT01696253What this trial is testingMulti-center Controlled Clinical Trials in Alport Syndrome-A Feasibility StudyWho this might be right forAlport Syndrome University of Minnesota 360
Not applicableStudy completedNCT01312727What this trial is testingHereditary Tubulointerstitial NephritisWho this might be right forNephritis, InterstitialChronic Renal FailureGout+1 more Assistance Publique - Hôpitaux de Paris 225
Testing effectiveness (Phase 2)Looking for participantsNCT05003986What this trial is testingStudy of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular DiseasesWho this might be right forFocal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more Travere Therapeutics, Inc. 67
Not applicableStudy completedNCT05687474What this trial is testingBaby Detect : Genomic Newborn ScreeningWho this might be right forCongenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more Centre Hospitalier Universitaire de Liege 6,824
Testing effectiveness (Phase 2)Active Not RecruitingNCT04573920What this trial is testingAtrasentan in Patients With Proteinuric Glomerular DiseasesWho this might be right forIgA NephropathyFocal Segmental GlomerulosclerosisAlport Syndrome+3 more Novartis Pharmaceuticals 103
Not applicableStudy completedNCT02555059What this trial is testingSpecial Drug Use Investigation of Ciproxan Injection in PediatricsWho this might be right forCystitis / Pyelonephritis / Cystic Fibrosis / Anthrax Bayer 48
Not applicableNot Yet RecruitingNCT05133050What this trial is testingSafety and Efficacy of ACEI in Alport Syndrome Patients With COL4A3/COL4A4/COL4A5 VariantsWho this might be right forAlport Syndrome Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 510
Not applicableEnrolling By InvitationNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07211685What this trial is testingBAY3401016; Biomarker Study AlportWho this might be right forAlport Syndrome Bayer 60
Large-scale testing (Phase 3)Study completedNCT01485978What this trial is testingEfficacy and Safety Study to Delay Renal Failure in Children With Alport SyndromeWho this might be right forRenal Insufficiency, Chronic Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 66
Not applicableStudy completedNCT03836144What this trial is testingEffect of Urine Alkalinazation on Urinary Inflammatory Markers in Patients With CystinuriaWho this might be right forCystinuriaRenal LithiasisGlomerulonephritis+1 more European Georges Pompidou Hospital 63
Not applicableEnded earlyNCT02718027What this trial is testingBiomarker for Alport Syndrome (BioAlport)Who this might be right forNephritis, HereditaryHematuria-Nephropathy-Deafness Syndrome CENTOGENE GmbH Rostock 12